DWP
IDXX icon

Daymark Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Daymark Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Buy
647
+26
+4% +$14.6K 0.01% 591
2026
Q1 		$349K Buy
621
+3
+0.5% +$1.92K 0.01% 525
2025
Q4 		$418K Buy
618
+1
+0.2% +$681 0.01% 431
2025
Q3 		$394K Buy
617
+21
+4% +$12.7K 0.01% 429
2025
Q2 		$320K Sell
596
-27
-4% -$12.9K 0.01% 434
2025
Q1 		$262K Buy
623
+18
+3% +$7.82K 0.01% 440
2024
Q4 		$250K Sell
605
-2
-0.3% -$877 0.01% 442
2024
Q3 		$307K Sell
607
-14
-2% -$6.8K 0.01% 418
2024
Q2 		$303K Buy
621
+168
+37% +$84.3K 0.01% 398
2024
Q1 		$245K Buy
+453
New +$248K 0.01% 381

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Daymark Wealth Partners's IDXX Position: Q2 2026 in Review

Daymark Wealth Partners increased its Idexx Laboratories (IDXX) stake by 4.2% in Q2 2026, buying an estimated $14.6K and bringing the position to 647 shares worth $341K. The position accounts for 0.01% of the portfolio, ranked #591.

Daymark Wealth Partners first reported a position in IDXX in Q1 2024 and has held it in 10 quarters since. The position peaked at $418K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Daymark Wealth Partners held 647 shares of Idexx Laboratories worth $341K as of Q2 2026.
  • Daymark Wealth Partners bought 26 Idexx Laboratories shares in Q2 2026, an estimated $14.6K.
  • Idexx Laboratories made up 0.01% of Daymark Wealth Partners's portfolio in Q2 2026, its #591 holding.
  • Daymark Wealth Partners first reported a position in Idexx Laboratories in Q1 2024 and has held it in 10 quarters since.
  • Daymark Wealth Partners's Idexx Laboratories position peaked at $418K in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.